Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Iloprost for Raynaud's in Systemic Sclerosis
NCT00004786Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Dec 1995
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of iloprost in Raynaud phenomenon, sponsored by National Center for Research Resources. Started Dec 1995; status: completed.
02
Drugs
iloprost
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT00004786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004786.